Valuation : Kenvue Inc.

Market Cap 34.15B 29.42B 27.86B 25.25B 47.38B 3,263B 47.62B 331B 127B 1,660B 128B 125B 5,245B P/E 2026 *
18.7x
P/E 2027 * 16.3x
Enterprise Value 41.25B 35.54B 33.65B 30.5B 57.23B 3,941B 57.52B 400B 154B 2,005B 155B 152B 6,335B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.55x
Free-Float
98.88%
Yield 2026 *
4.75%
Yield 2027 * 4.85%
1 day-0.06%
1 week-5.12%
Current month-5.83%
1 month-6.67%
3 months-1.60%
6 months+0.74%
Current year+3.07%
1 week 17.6
Extreme 17.6
18.65
1 month 17.6
Extreme 17.6
19.56
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%-5.12%-5.68%-19.44% 34.17B
+1.61%-0.80%-8.42%-6.13% 332B
-0.16%-4.44%-12.69%-0.07% 133B
-1.25%-2.22%+3.26%+17.38% 70.07B
-0.79%-2.35%-26.51%-24.02% 47.73B
+0.67%-6.49%+11.88%-36.65% 34.9B
-1.51%-3.09%+0.50%+21.94% 20.2B
-0.03%-4.08%-22.41%-40.02% 18.6B
-0.53%-4.00%+2.96%+6.31% 18.43B
-0.56%-1.48%-31.70%-16.34% 9.31B
Average -0.43%-3.33%-8.88%-9.70% 71.83B
Weighted average by Cap. -0.28%-2.39%-8.28%-5.92%

Financials

2026 *2027 *
Net sales 15.6B 13.44B 12.72B 11.53B 21.64B 1,490B 21.74B 151B 58.11B 758B 58.57B 57.28B 2,395B 15.97B 13.76B 13.03B 11.81B 22.15B 1,525B 22.26B 155B 59.49B 776B 59.96B 58.65B 2,452B
Net income 1.83B 1.57B 1.49B 1.35B 2.53B 175B 2.55B 17.7B 6.81B 88.8B 6.86B 6.71B 281B 2.1B 1.81B 1.71B 1.55B 2.92B 201B 2.93B 20.37B 7.83B 102B 7.89B 7.72B 323B
Net Debt 7.1B 6.12B 5.79B 5.25B 9.85B 678B 9.9B 68.79B 26.45B 345B 26.66B 26.08B 1,090B 6.53B 5.63B 5.33B 4.83B 9.06B 624B 9.11B 63.29B 24.34B 317B 24.53B 23.99B 1,003B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-11 US$17.78 -0.06% 47,161,103
26-09-10 US$17.79 +0.23% 64,381,576
26-09-09 US$17.75 -3.48% 24,488,532
26-09-08 US$18.39 -1.87% 16,220,487
26-09-04 US$18.74 -1.11% 26,856,871
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.78USD
Average target price
19.50USD
Spread / Average Target
+9.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!